Concepedia
Statistics
Publications
10
Citations
956
H-Index
Active since
1993
Affiliations
University of Basel(Current)
University Hospital of Basel
Novartis (Switzerland)
Novartis Institutes for BioMedical Research
University Hospital Cologne
Kea Martin is an author at University of Basel specializing in immunology, life sciences, and oncology.
Publications per year
1993–2021
Trastuzumab emtansine (T-DM1) renders HER2 <sup>+</sup> breast cancer highly susceptible to CTLA-4/PD-1 blockade
Philipp Müller, Matthias Kreuzaler, Tarik A. Khan et al. · Science Translational Medicine · 2015 · 335 citations
Medicine, Oncology, Pharmacology +17
Microtubule-Depolymerizing Agents Used in Antibody–Drug Conjugates Induce Antitumor Immunity by Stimulation of Dendritic Cells
Philipp Müller, Kea Martin, Sebastian Theurich et al. · Cancer Immunology Research · 2014 · 196 citations
Medicine, Immunology, Oncology +17
Immune cell landscaping reveals a protective role for regulatory T cells during kidney injury and fibrosis
Fernanda do Valle Durães, Armelle Lafont, Martin Beibel et al. · JCI Insight · 2020 · 151 citations · Full text
Life Sciences, Immunology, Pathobiology +17
The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity
Kea Martin, Philipp Müller, Jens Schreiner et al. · Cancer Immunology Immunotherapy · 2014 · 76 citations · Full text
Life Sciences, Immunology, Oncology +12
GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses
Abhishek S. Kashyap, Laura Fernández Rodríguez, Yun Zhao et al. · Cell Reports · 2019 · 74 citations · Full text
Life Sciences, Cell Biology, Immunology +17
1–5 of 10